Prevalence, awareness, treatment, and control of diabetes in India: a nationally representative survey of adults aged 45 years and older

作者：T. V. Sekher, David Flood, Hunter Green, Peifeng Hu, Mohammed K. Ali, Ashwini Shete, Sarang Pedgaonkar, Kenneth M. Langa, Eileen M. Crimmins, David E. Bloom, Jinkook Lee · 发表于：The Lancet Global Health · 年份：2025 · DOI：10.1016/s2214-109x(23)00502-8 · 被引用次数：18 · 研究领域：Diabetes, Cardiovascular Risks, and Lipoproteins、Diabetes Treatment and Management、Diabetes Management and Education

Background India is a country of 1·4 billion people that contributes to much of the global diabetes burden. Updated evidence on the state of the diabetes epidemic among middle-aged and older adults is imperative given that the risk of diabetes increases with age and that clinical and public health interventions can prevent diabetes complications. We aimed to estimate the prevalence, awareness, treatment, and control of diabetes in a nationally representative and state-representative sample of Indians aged 45 years and older. Methods We conducted a cross-sectional, nationally representative survey of adults in India aged 45 years and older and their spouses from 2017 to 2019. Our sample included 57 810 individuals and their spouses from 36 states and union territories, reflecting a representative sample of India as a nation and of each state and union territory. Participants had available data on glycated haemoglobin (HbA 1c ) measurement and non-missing information on diabetes diagnosis, household economic status, and BMI. Spouses younger than 45 years were excluded from the analysis. Our primary outcomes were diabetes prevalence and health service indicators recommended by WHO. Diabetes prevalence was defined as individuals self-reporting a previous diabetes diagnosis or having HbA 1c of 6·5% or higher. Available data did not allow the identification of type 1 versus type 2 diabetes. Diabetes health service indicators were based on four core metrics recommended by WHO: (1) p...